New registry aims to unlock secrets of rare gynecologic condition
NCT ID NCT03564483
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is creating a registry of 100 women with extramammary Paget's disease (EMPD) of the vulva or perianal area. Researchers will collect health information, tissue samples, and skin swabs to learn more about the disease and the bacteria living on affected skin. The goal is to better understand EMPD and track long-term outcomes, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Feb 2018
- Expected to finish
-
Dec 2050
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Women diagnosed with Extramammary Paget's Disease
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Females * Age 18 years or older * Diagnosed with primary or recurrent EMPD of vulva and/or perianal region of the body * Willing and able to provide signed informed consent Exclusion Criteria: * Males * Diagnosis of Paget's Disease in body areas other than vulvar or perianal region
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Extramammary Paget disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New light treatment offers hope for rare vulvar cancer
- Glow-in-the-Dark dye could help surgeons spot hidden cancer cells
- New virus therapy takes on advanced cancers in first human trial
- Immunotherapy duo takes on rare tumors
- Cancer-Fighting virus teams up with immunotherapy to tackle rare skin tumors